Tag Archives | Professor Falasca is currently collaborating with specialist cannabinoid bio-pharmaceutical company Zelda Therapeutics

Cannabinoid mice trial gives hope for treating pancreatic cancer patients

A naturally occurring cannabinoid could provide hope for pancreatic cancer patients after breakthrough research by Curtin University found it strongly enhanced the effectiveness of the chemotherapy drug Gemcitabine in mice. Scientists at Curtin and Queen Mary University of London tested the impact the naturally occurring cannabinoid ‘Cannabidiol’ had on the use of Gemcitabine as a treatment for pancreatic cancer in mice. Lead author Curtin University Professor Marco Falasca said the the research indicated the mice, whose form of the […]